The hospital pharmacies dominated the segment during forecast period. Doctors and hospital pharmacists are an essential component of the segment because pharmacists assist patients with the disease ...

Jazz Pharmaceuticals Announces Initiation of Phase 3 Trial Evaluating Epidiolex®/Epidyolex® (cannabidiol) for Patients with Epilepsy with Myoclonic-Atonic Seizures ...

More than 3.4 million people in the United States have epilepsy, so it is a relatively common diagnosis. In fact, it is the fourth-most common neurologic condition in the world. November is National ...

More than 3.4 million people in the US and 65 million people worldwide have epilepsy, a neurological disorder that affects the nervous system and causes seizures. One in 26 people will develop ...

For individuals with a severe form of epilepsy, a new study finds that the occurrence of seizures could be significantly reduced with a daily dose of cannabidiol – a chemical component of cannabis.

These seizures affect both sides of the brain and often result in loss of consciousness. Absence seizures, previously known as petit mal seizures, cause a brief lapse in awareness, while tonic-clonic ...

Active ingredient: Rufinamide 200 mg, 400 mg; scored tabs. Indication: Adjunctive treatment of seizures in Lennox-Gastaut syndrome (LGS). Pharmacology: LGS is a seizure disorder characterized by ...

A seizure occurs when there is abnormal electrical activity in the brain. There are different types of seizures depending on where and how much brain activity is affected. If someone is seizing make ...

Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder is a rare, genetically determined developmental and epileptic encephalopathy characterized by early-onset refractory seizures and severe ...

ALBANY, N.Y. (NEWS10) – Epilepsy is the fourth most common neurological disorder in the United States and can impact women and men. An estimated 3.4 million people in the U.S. have epilepsy, but there ...